🇺🇸 FDA
Patent

US 8628780

Lutzomyia longipalpis polypeptides and methods of use

granted A61KA61K2039/53A61K2039/57

Quick answer

US patent 8628780 (Lutzomyia longipalpis polypeptides and methods of use) held by The United States of America as Represented by the Secretary of the Department of Health and Human Services expires Mon Jan 09 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America as Represented by the Secretary of the Department of Health and Human Services
Grant date
Tue Jan 14 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 09 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
12
CPC classes
A61K, A61K2039/53, A61K2039/57, A61K2039/575, A61K2039/58